Did you know that lung cancer is the leading cause of cancer deaths in the United States with more people dying of lung cancer than breast, prostate, colon, and kidney cancers combined?

Most cases of lung cancers are diagnosed in later stages with limited treatment options and high mortality rates. Actively screening the high risk population for lung cancer has shown significant benefits in terms of earlier diagnosis and increased survival rates.

Join Interventional Pulmonologist Dr. Deepankar Sharma of the Lung Institute for a discussion on current screening practices, why they are so important, and what the future looks like for this process.